Of note, PI3K/AKT/mTOR signaling has been described to be involved in resistance to specific inhibitors classically employed in NMSCs, due to the intricate crosstalk between different pathways in these skin cancers (70, 117). This evidence concerns the gene AKT1 and skin neoplasm.